- Latest available (Revised)
- Point in Time (31/12/2020)
- Original (As made)
The National Health Service (Cross-Border Healthcare and Miscellaneous Amendments etc.) (EU Exit) Regulations 2019
You are here:
What Version
Advanced Features
- Show Geographical Extent(e.g. England, Wales, Scotland and Northern Ireland)
- Show Timeline of Changes
More Resources
Status:
Point in time view as at 31/12/2020.
Changes to legislation:
There are currently no known outstanding effects for the The National Health Service (Cross-Border Healthcare and Miscellaneous Amendments etc.) (EU Exit) Regulations 2019, PART 2.
Changes to Legislation
Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.
PART 2U.K.Amendments to primary legislation
The Health and Social Security Act 1984U.K.
2.—(1) The Health and Social Security Act 1984 M1 is amended as follows.
(2) Omit section 10 (reimbursement of cost of medical and maternity treatment in member States of European Economic Community).
(3) In section 26(4) (extent) omit “section 10”.
Commencement Information
I1Reg. 2 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1(1)
Marginal Citations
M11984 c.48. Functions under section 10 were, so far as exercisable in relation to Wales, transferred to the National Assembly for Wales by article 2 of, and Schedule 1 to, S.I. 1999/672; those functions are now exercisable by the Welsh Ministers by virtue of paragraph 30 of Schedule 11 to the Government of Wales Act 2006 (c.32).
The National Health Service Act 2006U.K.
3. In the NHS Act 2006 omit the following provisions—
(a)section 6A (reimbursement of cost of services provided in another EEA state) M2;
(b)section 6B (prior authorisation for the purposes of section 6A) M3;
(c)section 6BA (reimbursement of cost of services provided in another EEA state where expenditure incurred on or after 25 October 2013) M4;
(d)section 6BB (prior authorisation for the purposes of section 6BA) M5;
(e)section 6D (regulations relating to EU obligations) M6;
(f)section 6E(7)(b) (regulations as to the exercise of functions by the Board or clinical commissioning groups) M7;
(g)section 183(a)(ii) (payment of travelling expenses) M8;
(h)the definition of “Regulation (EC) No. 883/2004” in section 275(1) (interpretation) M9 except in so far as it relates to section 183(a)(iii).
Commencement Information
I2Reg. 3 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1(1)
Marginal Citations
M2Section 6A was inserted by S.I. 2010/915 and amended by paragraph 3 of Schedule 4 to the Health and Social Care Act 2012 (c.7) (“the 2012 Act”) and S.I. 2013/2269.
M3Section 6B was inserted by S.I. 2010/915 and amended by paragraph 4 of Schedule 4 to the 2012 Act.
M4Section 6BA was inserted by S.I. 2013/2269.
M5Section 6BB was inserted by S.I. 2013/2269.
M6Section 6D was inserted by section 19 of the 2012 Act.
M7Section 6E was inserted by section 20 of the 2012 Act.
M8Section 183(a) was substituted by S.I. 2010/915 and amended by paragraph 98 of Schedule 4 to the 2012 Act and by S.I. 2013/2269.
M9The definition was inserted by S.I. 2010/915.
The National Health Service (Wales) Act 2006U.K.
4.—(1) The NHS (Wales) Act is amended as follows.
(2) In section 46 (GMS contracts: prescription of drugs, etc)—
(a)in subsection (3), for “Community marketing authorization or United Kingdom” substitute “ UK ”;
(b)for subsection (4) substitute—
“(4) “UK marketing authorisation” has the meaning given by regulation 8(1) of the Human Medicines Regulations 2012 (S.I. 2012/1916).”.
(3) Omit the following provisions—
(a)section 6A (reimbursement of cost of services provided in another EEA state) M10;
(b)section 6B (prior authorisation for the purposes of section 6A) M11;
(c)section 6BA (reimbursement of cost of services provided in another EEA state where expenditure incurred on or after 25 October 2013) M12;
(d)section 6BB (prior authorisation for the purposes of section 6BA) M13;
(e)section 131(a)(ii) (payment of travelling expenses) M14;
(f)the definition of “Regulation (EC) No. 883/2004” in section 206(1) (interpretation) M15 except in so far as it relates to section 131(a)(iii).
Commencement Information
I3Reg. 4 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1(1)
Marginal Citations
M10Section 6A was inserted by S.I. 2010/915 and amended by S.I. 2013/2269.
M11Section 6B was inserted by S.I. 2010/915 and amended by S.I. 2013/2269.
M12Section 6BA was inserted by S.I. 2013/2269.
M13Section 6BB was inserted by S.I. 2013/2269.
M14Section 131(a) was substituted by S.I. 2010/915 and amended by S.I. 2013/2269.
M15The definition was inserted by S.I. 2010/915.
The Health and Social Care Act 2012U.K.
5. In the Health and Social Care Act 2012 M16 omit the following provisions—
(a)section 124(9) (local modifications of prices: agreements);
(b)section 125(9) (local modifications of prices: applications).
Commencement Information
I4Reg. 5 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1(1)
Marginal Citations
The Cities and Local Government Devolution Act 2016U.K.
6. In the Cities and Local Government Devolution Act 2016 M17 omit section 18(2)(b) (devolving health service functions).
Options/Help
Print Options
PrintThe Whole Instrument
PrintThis Part only
Legislation is available in different versions:
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Point in Time: This becomes available after navigating to view revised legislation as it stood at a certain point in time via Advanced Features > Show Timeline of Changes or via a point in time advanced search.
See additional information alongside the content
Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.
Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.
Opening Options
Different options to open legislation in order to view more content on screen at once
Explanatory Memorandum
Explanatory Memorandum sets out a brief statement of the purpose of a Statutory Instrument and provides information about its policy objective and policy implications. They aim to make the Statutory Instrument accessible to readers who are not legally qualified and accompany any Statutory Instrument or Draft Statutory Instrument laid before Parliament from June 2004 onwards.
More Resources
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
- the original print PDF of the as enacted version that was used for the print copy
- lists of changes made by and/or affecting this legislation item
- confers power and blanket amendment details
- all formats of all associated documents
- correction slips
- links to related legislation and further information resources
Impact Assessments
Impact Assessments generally accompany all UK Government interventions of a regulatory nature that affect the private sector, civil society organisations and public services. They apply regardless of whether the regulation originates from a domestic or international source and can accompany primary (Acts etc) and secondary legislation (SIs). An Impact Assessment allows those with an interest in the policy area to understand:
- Why the government is proposing to intervene;
- The main options the government is considering, and which one is preferred;
- How and to what extent new policies may impact on them; and,
- The estimated costs and benefits of proposed measures.
Timeline of Changes
This timeline shows the different points in time where a change occurred. The dates will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. The first date in the timeline will usually be the earliest date when the provision came into force. In some cases the first date is 01/02/1991 (or for Northern Ireland legislation 01/01/2006). This date is our basedate. No versions before this date are available. For further information see the Editorial Practice Guide and Glossary under Help.
More Resources
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
- the original print PDF of the as made version that was used for the print copy
- correction slips
Click 'View More' or select 'More Resources' tab for additional information including:
- lists of changes made by and/or affecting this legislation item
- confers power and blanket amendment details
- all formats of all associated documents
- links to related legislation and further information resources
All content is available under the Open Government Licence v3.0 except where otherwise stated. This site additionally contains content derived from EUR-Lex, reused under the terms of the Commission Decision 2011/833/EU on the reuse of documents from the EU institutions. For more information see the EUR-Lex public statement on re-use.